Cargando…
Caveat emptor: for researchers, a rose will not smell sweet unless we know its composition
In a recent publication in Bioscience Reports “Contaminants in commercial preparations of ‘purified’ small leucine-rich proteoglycans may distort mechanistic studies”, Brown et al. identified by mass spectrometry and immunoblotting that certain commercial preparations of the small leucine-rich prote...
Autor principal: | Adams, Josephine C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426283/ https://www.ncbi.nlm.nih.gov/pubmed/28356486 http://dx.doi.org/10.1042/BSR20170078 |
Ejemplares similares
-
Caveat emptor
por: Aswani, Yashant, et al.
Publicado: (2015) -
Caveat emptor: the combined effects of multiplicity and selective reporting
por: Li, Tianjing, et al.
Publicado: (2018) -
Shorter course of trastuzumab: Caveat emptor
por: Venniyoor, Ajit
Publicado: (2011) -
New implants in orthopaedics – caveat emptor
por: Warwick, D, et al.
Publicado: (2012) -
Caveat Pre-Emptor: Contextualising peer review and publication
Publicado: (2019)